Unusual circulating anticoagulant in a patient with systemic lupus erythematosus.
Unusual circulating anticoagulant in a patient with systemic lupus erythematosus.
复制标题
系统性红斑狼疮患者的异常循环抗凝剂。
DOI:
10.1159/000207332
复制
发表时间:
1963
影响因子:
2.4
通讯作者:
E. Torre López
中科院分区:
文献类型:
--
作者:
L. Sánchez;R. Lisker;E. Torre López
Systemic lupus erythematosus (SLE) is a disease in which several types of autoimmune phenomena are commonly present. Among them, thrombocytopenic purpura, hemolytic anemia, and circulating anticoagulants are commonly seen; according to Mar-GOLIUS, Jackson AND Ratnoff (1), the latter complication has a frequency of 13%. In the majority of cases there have not been clinical hemorrhagic manifestations; the existence of the anti coagulant has been suspected during the performance of routine laboratory procedures. The usual type of circulating anticoagulant found in SLE, interferes with the conversion of prothrombin to thrombin (2), and therefore the prothrombin time is abnormal. Occasionally, it has shown antithrombin activity (3, 4) and only one case has been reported in which it behaved as an anti-thromboplastinogen (5). In other disease states related to SLE, such as penicillin sensitivity reactions, rheumatoid arthritis, pemphigus, etc., though rarely, anticoagulants interfering with thromboplastin formation have been reported (6). In some of these cases, inhibition of the antihemophilic globulin has been demonstrated. The patient described in this paper had a circulating anti coagulant active against a serum factor necessary for thrombo plastin generation. Some evidence that it acted against the Plasma Thromboplastin Component (PTC) was obtained.